Roivant announces FDA approval and U.S. availability of LISRAYA
Roivant Sciences announced FDA approval and U.S. availability of LISRAYA for dermatomyositis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.